EDGAR Filing Documents for 0001493152-24-007616

Form 8-K - Current report:

SEC Accession No. 0001493152-24-007616

Filing Date

2024-02-23

Accepted

2024-02-23 09:26:51

Documents

Period of Report

2024-02-19

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	85187
2		ex3-1.htm	EX-3.1	155939
3		ex4-1.htm	EX-4.1	85865
4		ex10-1.htm	EX-10.1	397454
5		ex10-2.htm	EX-10.2	165688
6		ex99-1.htm	EX-99.1	18616
	Complete submission text file	0001493152-24-007616.txt		1317468

Data Files

Seq	Description	Document	Type	Size
7	XBRL SCHEMA FILE	bfri-20240219.xsd	EX-101.SCH	3967
8	XBRL DEFINITION FILE	bfri-20240219_def.xml	EX-101.DEF	27426
9	XBRL LABEL FILE	bfri-20240219_lab.xml	EX-101.LAB	37912
10	XBRL PRESENTATION FILE	bfri-20240219_pre.xml	EX-101.PRE	26043
22	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	6916

Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801

Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325

Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)